Geldanamycin provides posttreatment protection against glutamate- induced oxidative toxicity in a mouse hippocampal cell line

Nianqing Xiao, Clifton W. Callaway, Christopher A. Lipinski, Shawn D. Hicks, Donald B. DeFranco

Research output: Contribution to journalArticle

48 Scopus citations

Abstract

The benzoquinoid ansamycin geldanamycin interferes with many cell signaling pathways and is currently being evaluated as an anticancer agent. The main intracellular target of geldanamycin is the 90-kDa heat shock protein, hsp90. In this report we demonstrate that geldanamycin is effective at preventing glutamate-induced oxidative toxicity in the HT22 mouse hippocampal cell line, even if given 4 h after glutamate treatment. Geldanamycin prevents glutamate-induced internucleosomal DNA cleavage in the HT22 cells but does not reverse the depletion of glutathione levels brought about by glutamate treatment. Both anabolic and catabolic effects are generated by geldanamycin treatment of HT22 cells, as evidenced by the induction of hsp70 expression and degradation of c-Raf-1 protein, respectively. Thus, geldanamycin may provide an effective strategy for manipulating signaling pathways in neuronal cells that use hsp90 as they proceed through a programmed cell death pathway in response to oxidative stress.

Original languageEnglish (US)
Pages (from-to)95-101
Number of pages7
JournalJournal of neurochemistry
Volume72
Issue number1
DOIs
StatePublished - Jan 11 1999

Keywords

  • Geldanamycin
  • Heat shock proteins
  • Oxidative toxicity

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Fingerprint Dive into the research topics of 'Geldanamycin provides posttreatment protection against glutamate- induced oxidative toxicity in a mouse hippocampal cell line'. Together they form a unique fingerprint.

  • Cite this